Company Monitoring Page for BeiGene

latest headlines for company on cafepharma

This Week at FDA: Pallone pushes for greater ClinicalTrials.gov enforcement, FDA rejects Eli Lilly Alzheimer’s drug, and more
RAPS.org
Sun, 01/22/23 - 01:00 pm
Tags:
FDA, regulatory, clinical trials, clinicaltrials.gov, Eli Lilly, donanemab, Medtronic, BeiGene, Seagen
BeiGene's Brukinsa wins CLL approval after topping Imbruvica in head-to-head trial
Endpoints
Thu, 01/19/23 - 08:55 pm
Tags:
BeiGene, Brukinsa, CLL, FDA, Imbruvica
Big caps bounce back for biopharma
EP Vantage
Mon, 01/16/23 - 11:14 am
Tags:
pharma stocks, Amgen, BeiGene, Bristol Myers Squibb, Gilead Sciences, Lantheus Holdings, Madrigal Pharmaceuticals, Merck, Moderna Therapeutics, Novo Nordisk, Prometheus Biosciences, Roche
ASH 2022 – pirtobrutinib leads the post-Imbruvica charge
EP Vantage
Wed, 12/14/22 - 10:18 am
Tags:
ASH 2022, Eli Lilly, BeiGene, Nurix Therapeutics, Brukinsa, pirtobrutinib, NX-2127
Go or no go? Mirati heads to the FDA
EP Vantage
Wed, 11/30/22 - 10:34 am
Tags:
FDA, Mirati Therapeutics, Gilead Sciences, Coherus Biosciences, Roche, Biogen, TG Therapeutics, Ipsen, Novartis, BeiGene, Cytokinetics
Few safe havens surface in another down quarter for biopharma
EP Vantage
Fri, 10/14/22 - 10:03 am
Tags:
biopharma stocks, COVID-19, Eli Lilly, Bristol Myers Squibb, Merck, Daiichi Sankyo, Vertex Pharmaceuticals, Takeda, Neurocrine, Sarepta Therapeutics, Orion, Pfizer, GSK, Roche, Moderna Therapeutics, BeiGene, BioNTech, Novavax, CureVac
BeiGene heaps more pressure on AbbVie, J&J with new Brukinsa head-to-head win over Imbruvica
Fierce Pharma
Wed, 10/12/22 - 11:00 am
Tags:
BeiGene, AbbVie, JNJ, Imbruvica, blood cancers, Brukinsa
ESMO 2022 – the new liver cancer entrants line up
EP Vantage
Thu, 09/8/22 - 10:39 am
Tags:
ESMO, liver cancer, Keytruda, tislelizumab, camrelizumab, Merck, BeiGene, Novartis
BeiGene and Novartis Make Late-Stage Progress against Liver Cancer
BioSpace
Tue, 08/9/22 - 12:14 pm
Tags:
Novartis, BeiGene, hepatocellular carcinoma, liver cancer, clinical trials
FDA Indefinitely Delays BeiGene/Novartis anti-PD-1 Esophageal Cancer Drug
BioSpace
Thu, 07/14/22 - 10:51 am
Tags:
Novartis, BeiGene, FDA, tislelizumab, esophageal cancer
Doubling down on mRNA, BeiGene taps rising Hong Kong star to create targeted therapies
Fierce Biotech
Wed, 07/6/22 - 10:52 am
Tags:
BeiGene, MRNA, drug discovery, Strand Therapeutics, InnoRNA, R&D
Novartis, BeiGene lay out frontline PhIII data for PD-1 drug as second-line PDUFA date looms
Endpoints
Thu, 06/30/22 - 12:11 pm
Tags:
Novartis, BeiGene, FDA, tislelizumab, gastrointestinal cancer
BeiGene Reports Lucrative Q1 Amid SEC Audit
BioSpace
Sun, 05/8/22 - 12:08 pm
Tags:
BeiGene, earnings
Novartis records another tislelizumab win en route to bringing BeiGene's PD-1 to FDA's doors
Endpoints
Wed, 04/27/22 - 10:32 am
Tags:
Novartis, BeiGene, tislelizumab, esophageal cancer
Outside of big pharma, life remains tough for listed developers
EP Vantage
Wed, 04/20/22 - 10:38 am
Tags:
pharma stocks, AbbVie, AstraZeneca, BeiGene, BioNTech, Moderna Therapeutics, Pfizer, Roche
JPM22, Day 3: BeiGene, Ionis promise 'tidal wave' of new drugs; Roche launches smart, point-of-care glucose monitor
Fierce Biotech
Wed, 01/12/22 - 11:12 am
Tags:
JPMHC 2022, BeiGene, Ionis Pharmaceuticals, Roche, devices, AstraZeneca, Biogen
Novartis Deepens BeiGene Oncology Pact, Posts Disappointing Results in CSU
BioSpace
Mon, 12/20/21 - 10:49 am
Tags:
Novartis, BeiGene, China, ociperlimab, anti-TIGIT
Biotech BeiGene slides in Shanghai after $3.5 bln STAR debut
Yahoo/Reuters
Wed, 12/15/21 - 10:39 am
Tags:
BeiGene, STAR market, China, Shanghai
Licensing deals rack up in 2021
EP Vantage
Fri, 12/10/21 - 10:46 am
Tags:
licensing, GSK, Alector, Novartis, BeiGene, Pfizer, Arvinas, iTeos Therapeutics, Bristol Myers Squibb, Eisai
ASH: Chasing AbbVie and J&J's Imbruvica, BeiGene's Brukinsa fleshes out competitive leukemia data again
Fierce Biotech
Thu, 11/4/21 - 10:27 am
Tags:
BeiGene, Brukinsa, leukemia, clinical trials, AbbVie, JNJ, Imbruvica

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.